4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000137
Director acquired 5,967 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1717540199.xml…